The phytocompound (100–200 μM) inhibits in vitro the proliferation, migration, and promotes apoptosis on SKOV3 human ovarian cancer cells by down regulating the mRNA levels of N-cadherin and also the gamma-aminobutyric acid (GABAB) receptor [59]. Here, CDH2 is linked to ovarian carcinoma.